4//SEC Filing
Jagpal Netta 4
Accession 0001213900-24-111568
CIK 0001728328other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 9:26 AM ET
Size
5.7 KB
Accession
0001213900-24-111568
Insider Transaction Report
Form 4
Jagpal Netta
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-12-20+3,750→ 6,250 totalExercise: $4.14Exp: 2029-12-19→ Common shares (3,750 underlying)
Footnotes (2)
- [F1]The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month).
- [F2]On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split.
Documents
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeother
Related Parties
1- filerCIK 0002013468
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 9:26 AM ET
- Size
- 5.7 KB